纤溶酶原激活因子和抑制因子在生殖中的作用

综述了由纤溶酶原激活因子（ＰＡ）和抑制因子（ＰＡＩ）所调控的局部定向纤蛋白水解在生殖作用研究中的最新进展。组织型（ｔ）ＰＡ（ｔＰＡ）和Ｉ型ＰＡＩ（ＰＡＩ－１）在卵巢不同细胞中的协同表达参与排卵和黄体（ＣＬ）萎缩调控过程,在早期黄体组织中尿激酶型（ｕ）ＰＡ（ｕＰＡ）和ＰＡＩ－１活性明显增高,ｕＰＡ和ＰＡＩ－１的协同表达可能与黄体形成过程中组织重建和血管发生密切相关。实验证明,ＰＡ系统在精子发生和成熟     

肌肉电针介导VEGF基因治疗大鼠闭塞性血管病

应用电针介导血管内皮生长因子 (VEGF)基因治疗实验性外周血管闭塞症大鼠 ,以RT PCR及免疫组化方法观察VEGF基因的表达 ,通过血管造影技术观察VEGF基因导入大鼠体内后的生物效应 .结果显示 ,电针介导VEGF基因可在大鼠肌肉组织高效表达VEGF ,并可促进局部组织新生血管形成和侧枝循环建立 ,使血流恢复 ,为闭塞性血管病的基因治疗提供一种新的基因转移方法 .     

肿瘤血管生成抑制剂的研究现状及我国的发展战略探讨

肿瘤血管生成抑制剂是一类能破坏或抑制血管生成,有效地阻止肿瘤的生长和转移的药物。按作用机制可分为五大类：（１）抑制基底膜降解;（２）直接抑制内皮细胞增殖;（３）抑制血管生长因子活化;（４）抑制内皮细胞特异性整合素／生存信号;（５）其它非特异性作用机制的药物。本文主要介绍了肿瘤血管生成抑制剂的研究现状,并对我国在肿瘤血管生成抑制剂研究方面可采取的战略进行了探讨。     

Homoharringtonine induces apoptosis of endothelium and down－regulates VEGF expression of K562 cells

Homoharringtonine (HHT) has currently been used successfully in the treatment of acute and chronic myeloid leukemias and has been shown to induce apoptosis of different types of leukemic cells in vitro. Emerging evidence suggests that angiogenesis may play an important role in hematological malignancies, such as leukemia. However, whether HHT can relieve leukemia by anti-angiogenesis is still unknown. We investigated the anti-angiogenesis potential of HHT with the human umbilical vein endothelial cell line (ECV304) and leukemic cell line (K562) in vitro. Cellular proliferation was determined by MTT assay and apoptosis was analyzed by flow cytometry, The mRNA expression of vascular endothelial growth factor (VEGF) was assessed by RT-PCR and VEGF protein production was detected by Western blot. Inhibition of cell proliferation and induction of apoptosis by HHT were discovered in ECV304 cells, and appeared in a dose- and time-dependent manner, Also, treatment with HHT caused down-regulation of VEGF mRNA expression in K562 cells in similar dose- and time-dependent manner and inhibition of VEGF protein production in K562 cells in response to the enhancing concentration of HHT. The results demonstrated that HHT could also induce apoptosis in endothelium and down-regulate VEGF expression in K562 cells. In conclusion, we believe HHT has anti-angiogenesis potential and speculate that HHT might exert its anti-leukemia effects via reduction of angiogenesis.     

530 nm和632.8 nm波长光诱发血液的荧光光谱对比分析

取健康人静脉血,分别用530nm和632．8nm波长光照射血液并检测其荧光光谱。结果显示,这2种波长光在血液中所激发的荧光光谱结构有很大不同。530nm光引发的荧光辐射强度比较大;632．8nm波长光所产生的发射光谱在原激发光的长波和短波2个方向都有分布。这一结果提示,上述2种波长光与血液相互作用的过程有所不同,因而其对血液的生物效应也会有所差异,这对于进一步研究激光血液照射疗法的治疗机理具有一定的意义。     

Role of FGF-2／FGFR signaling pathway in cancer and its signification in breast cancer

Fibroblast growth factor-2 (FGF-2) is a member of a large family of proteins that bind heparin and heparan sulfate and modulate the function of a wide range of cell types. It has been proved that FGF-2 stimulates the growth and development of new blood vessels (angiogenesis) that contribute to the pathogenesis of several diseases (i.e. cancer, atherosclerosis). However, many of the biological activities of FGF-2 have been found to depend on its receptor抯 intrinsic tyrosine kinase activity and second messengers such as the mitogen activated protein kinases. This review will focus on the mechanism of FGF-2/FGFR induced signaling pathway in tumor and human breast cancer.     

VEGF在小鼠膀胱癌肿瘤生长与转移中的作用

探讨VEGF在膀胱肿瘤生长和转移中的作用, 实验结果表明, 反义VEGF₁₂₁表达质粒转染能够明显降低肿瘤细胞产生VEGF. 稳定转染的克隆其VEGF的表达量仅为未转染的亲代细胞的12%及19%. 低水平表达VEGF的肿瘤细胞在体外的生长速度与未转染的亲代细胞间无明显差异, 但在同系小鼠体内的致瘤能力、生长速度及肺、肝等实质器官的转移率等均明显低于亲代细胞. 进一步比较高水平与低水平表达VEGF的肿瘤细胞对体外培养的小鼠血管内皮细胞生长的影响、体内肿瘤组织中微血管数目及通透性等, 证实膀胱癌细胞产生VEGF的能力与其诱导肿瘤新生血管形成的能力一致, 在肿瘤生长与转移过程中起重要作用.     

血管内皮生长因子在小鼠胚胎植入"窗口"的表达和功能

血管内皮生长因子（vascular endothelial growth factor ,VEGF)是一种特异作用于血管内皮细胞,与血管生成密切相关的生长因子,目前已知VEGF参与胚胎植入及胚胎的血管发生,但是仍不清楚VEGF在植入窗口期的表达情况和具体功能,实验应用离体和间接免疫荧光－激光共聚焦扫描等方法对VEGF在胚胎植入窗口的表达和功能进行了研究,研究发现,VEGF的分布在体外培养的处于植入“窗口”期的小鼠胚泡及其扩展的滋养层细胞和子宫上皮细胞单层上;VEGF抗体能够显著降低在体小鼠胚胎的着床数,在共培养体系中,VEGF抗体能够显著降低小鼠胚泡在子宫上皮细胞单层上的黏附率和扩展率,此作用具有剂量依赖关系,实验表明,VEGF是一种在胚胎植入过程中起重要作用的细胞因子,VEGF可能作为植入胚胎及接受性子宫内膜之间的“局部介导者”（local mediator),参与母胎间的信息传递,促进胚胎植入。     

手背静脉血管识别算法研究

由于指纹识别的易被污染性,虹膜识别给人造成的不舒服感等,为了克服这些已有的生物特征识别技术的缺点,本文对一种全新的生物特征识别方法——基于手背的静脉血管图像的特征识别算法进行了初步研究。提出了一种基于血管细化后的特征提取识别算法。分析了这种识别方法所要求的图像预处理过程,并对小数目样本进行仿真实验。实验证明,只要基于可靠的识别方案,手背静脉模式识别进行个人身份识别是完全可行的,具有良好的应用前景。